Chembio Diagnostics Inc.
CEMI
Get informed when a big investor buys or sells
+ FollowShare Statistics
| Market cap | $16.71 Million |
|---|---|
| Enterprise Value | $23.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.96 |
| Beta | 1.86 |
| Outstanding Shares | 24,299,000 |
Return
| Return on Equity | -140.05% |
|---|---|
| Return on Assets | -39.81% |
| Return on Invested Capital | -87.52% |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | 0.51 |
| Price to Sales | 0.46 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | 1.41 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chembio Diagnostics Inc.
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio's extensive scientific...
Relevant Senate Committees
This committee controls taxation, trade, and entitlement spending. Its decisions on corporate tax policy directly affect Chembio's profitability, while trade policy impacts its global supply chains and international sales. Potential Medicare/Medicaid reimbursement policies are also under its purview.
This committee directly allocates discretionary federal spending. Its subcommittees determine funding for public health programs, scientific research, and government agencies that are direct purchasers or support the market for Chembio's products, thus impacting their order books and revenue.
This committee directly regulates the FDA, which is the primary regulatory body for diagnostic devices. Its influence on drug approval processes, NIH funding for research, and healthcare policy profoundly impacts Chembio's product development, market access, and R&D.